Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Acasti Pharma Inc
ACST
Healthcare
Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH), a rare and life-threatening medical emergency, in which bleeding occurs over the surface of the brain in the subarachnoid space between the...
brain and skull; GTX-102, an oral mucosal spray targeting ataxia-telangiectasia (A-T), a progressive, neurodegenerative genetic disease that primarily impacts children causing severe disability; and GTX-101, a topical spray, targeting postherpetic neuralgia, a persistent and often debilitating neuropathic pain caused by nerve damage from the varicella zoster virus (shingles). The Company’s clinical assets have each been granted Orphan Drug Designation by the FDA, which provides seven years of marketing exclusivity post-launch in the United States, and additional intellectual property protection.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ACST)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(51)
•••
Canadian_101
X
View Profile
View Bullboard History
Post by
Canadian_101
on Jul 27, 2020 9:42am
7 Analysts says ACSTI is a BUY
Acasti Pharma Inc (NASDAQ:ACST) Receives Consensus Rating of “Buy” from Brokerages Posted by Max Byerly on Jul 27th, 2020 Acasti Pharma
...more
(3)
•••
Zamboni99
X
View Profile
View Bullboard History
Comment by
Zamboni99
on Jul 20, 2020 11:24pm
RE:The Statistical Analysis Plan can be reviewed b4 unblinding
You guys are smart!
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net
posted May 02, 2024 9:00am by
Xcyte Digital Corp.
-
|
"The addition of Webinar.net further enhances Xcyte's suite of solutions by adding a technology platform that was built for and hosted on the cloud with enterprise grade scale and security. Webinar.net infrastructure is built to handle millions of online presentation attendees from global businesses. This acquisition further enhances our revenue and EBITDA growth in alignment with our medium-term expansion objectives ...read more
(63)
•••
hydrocarbss
X
View Profile
View Bullboard History
Post by
hydrocarbss
on Jul 20, 2020 9:35am
The Statistical Analysis Plan can be reviewed b4 unblinding
From E9 STATISTICAL PRINCIPLES FOR CLINICAL TRIALS The statistical analysis plan (see Glossary) may be written as a separate document to be completed after finalising the protocol. In this
...more
(44)
•••
postie1
X
View Profile
View Bullboard History
Post by
postie1
on Jul 18, 2020 1:22pm
Less than 2 weeks
Acasti must have a good idea now of the data from TRILOGY 2 by now if they are going to have detailed report ready for the end of July.. As usual , watch the stock price and action. Maybe Friday was
...more
(1849)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jul 12, 2020 11:55pm
RE:losers and bustouts
....because you are looking in a mirror
(2)
•••
Dswidler
X
View Profile
View Bullboard History
Post by
Dswidler
on Jul 12, 2020 1:07pm
losers and bustouts
i see the same bustouts and losers are still thinking something good is going to come from this stock. the pros like me know its a fraud. the truth hurts. i am the king
(52)
•••
Francine01
X
View Profile
View Bullboard History
Comment by
Francine01
on Jul 08, 2020 6:01pm
RE:RE:Francine
*sell
(52)
•••
Francine01
X
View Profile
View Bullboard History
Comment by
Francine01
on Jul 08, 2020 5:59pm
RE:Francine
Nop. Didn't see a single share. Still all in. I will agree that the situation with Rec from Oppe, Riley and Wainright is funny, but how the markets works. So take it of leave it. I am on
...more
(3)
•••
boozehound3
X
View Profile
View Bullboard History
Post by
boozehound3
on Jul 08, 2020 5:10pm
Trifecta alright
1. Oppenheimer 2. Hb riley 3. Hc wainwright
(3)
•••
boozehound3
X
View Profile
View Bullboard History
Post by
boozehound3
on Jul 08, 2020 5:09pm
Francine
Is that you buying all these shares. Were you out walking again?
(3)
•••
boozehound3
X
View Profile
View Bullboard History
Post by
boozehound3
on Jul 08, 2020 5:03pm
Hands down
Most cortupt manipulated stock on the exchange.
(1849)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jul 08, 2020 3:07pm
RE:Raising $75 million US
3 agents vs 1 before.... In February 2019, we entered into an “at-the-market”, or ATM, sales agreement with B. Riley FBR, Inc., pursuant to which our common shares may be sold from time to
...more
(44)
•••
postie1
X
View Profile
View Bullboard History
Comment by
postie1
on Jul 08, 2020 2:26pm
RE:RE:RE:RE:RE:RE:RE:Raising $75 million US
Does anybody know if further testing is needed for sure. If the results of trial 2 are good then what? Share dilution would be a lot less if trial 2 is good. Does anybody really believe that nobody is
...more
(31)
•••
IIDraCII
X
View Profile
View Bullboard History
Comment by
IIDraCII
on Jul 08, 2020 1:44pm
RE:RE:RE:RE:RE:RE:Raising $75 million US
Did they not mention this ATM raise with the Q earnings release and on the conference call last week? Why is anyone surprised? I may be missing something here. These shares will also not
...more
(18)
•••
EternalPonzi
X
View Profile
View Bullboard History
Comment by
EternalPonzi
on Jul 08, 2020 11:31am
RE:RE:RE:RE:RE:Raising $75 million US
Well, I did warn that major dilution was coming. At today's price, outstanding share count will rise to approx 200 million - assuming they can attract buyers at today's price which I
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project